22
Views
3
CrossRef citations to date
0
Altmetric
Review

Is there a role for wine in cancer and the degenerative diseases of aging?

Pages 195-207 | Published online: 26 Jun 2009

References

  • Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A. 1995;92(12):5258–5265.
  • Smith MA, Perry G, Richey PL, et al. Oxidative damage in Alzheimer’s. Nature. 1996;382(6587):120–121.
  • Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF. Intake of flavonoids and risk of dementia. Eur J Epidemiol. 2000;16(4):357–363.
  • Olanow CW. The pathogenesis of cell death in Parkinson’s disease – 2007. Mov Disord. 2007;22(Suppl 17):S335–S442.
  • Kelner KL, Marx J. Patterns of aging. Science. 1996;273(5271):41.
  • Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology. 1990;1:342–348.
  • Marmot M, Brunner E. Alcohol and cardiovascular disease: the status of the J-shaped curve, Br Med J. 1991;303:565–568.
  • Thun MJ, Peto R, Lopez A, et al. Alcohol consumption and mortality among middle-aged and elderly US adults. N Eng J Med. 1997;337:1705–1714.
  • Kono S, Shinshi K, Ikeda N, Yanai F, Imanishi K. Prevalence of gallstone disease in relation to smoking, alcohol use, obesity and glucose tolerance: a study of self defence officials in Japan. Am J Epidemiol. 1992;36:787–791.
  • Holbrook TL, Barrett-Connor E. A prospective study of alcohol consumption and bone mineral density. Br Med J. 1993;306:1506–1509.
  • Lipton R. The effect of moderate alcohol consumption on the relationship between stress and depression. Am J Public Health. 1994;84:1913–1917.
  • Voigt LF, Kepsell TD, Nelson JL, Dugowson CE, Daling JR. Smoking, obesity, alcohol consumption and the risk of rheumatoid arthritis. Epidemiology. 1994;5:525–528.
  • La Vecchia C, Decarli A, Franceschi S, Ferraroni M, Pagano R. Prevalence of chronic diseases in alcohol abstainers. Epidemiology. 1995; 6:436–438.
  • Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use and the risk of diabetes in man. Br Med J. 1995;310:555–559.
  • Weisse ME, Eberly B, Person DA. Wine as a digestive aid: comparative antimicrobial effects of bismuth salicylate and red and white wine. Br Med J. 1995;311:1657–1660.
  • Brenner H, Rotherbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Heliobacter pylori infection: cross sectional study. Br Med J. 1997;315:1489–1492.
  • Obisesan TO, Hirsh R, Kosoko O, Carlson L, Parrott M. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES–1. J Am Geriatr Soc. 1998; 46:1–7.
  • Renaud SC, Gueguen R, Schenker J, d’Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology. 1998;9:184–188.
  • Roche A. Patterns, paradoxes and ambiguities of consumption. Perth, Australia: Second International Conference on Drinking Patterns and Their Consequences; February 1–5, 1998.
  • Heath DB. Alcohol and pleasure: a health perspective. In: Peele S and Grant M, editors. Alcohol and pleasure: A health perspective, Philadelphia, PA: Brunner/Mazel; 1999; p. 61–72.
  • Jackson R, Scragg R, Beaglehole R. Does recent alcohol consumption reduce the risk of acute myocardial infarction and coronary death in regular drinkers? Am J Epidemiol. 1992;136(7):819–824.
  • Palomaki H, Kaste M. Regular light-to-moderate intake of alcohol and the risk of ischemic stroke. Is there a beneficial effect? Stroke. 1993;24(12):1828–1832.
  • Stockley CS. Wine in moderation: how could and should recent in vitro and in vivo data be interpreted? Drug Alc Rev. 1998;17:365–376.
  • Klatsky AL. Drink to your health? Scientific American. 2003;288(2):74–81.
  • Elias PK, Elias MF, D’Agostino RB, Silbershatz H, Wolf PA. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol. 1999;150:580–589.
  • Zuccala G, Onder G, Pedone C, et al. Gruppo Italiano di Farmacoepidemiologia nell’Anziano Investigators. Dose-related impact of alcohol consumption on cognitive function in advanced age: results of a multicenter survey. Alcohol Clin Exp Res. 2001;25(12):1743–1748.
  • Stockley CS. Recommendations on alcohol consumption: an international perspective. Contemp Drug Prob. 2008;34:681–711.
  • Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prevent Med. 2004;38(5):613–619.
  • Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res. 2004;38(8):771–785.
  • Kroon PA, Clifford MN, Crozier A, et al. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr. 2004;80(1):15–21.
  • International Agency for Research on Cancer. Alcohol drinking. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 44. Lyon: IARC, 1988 [Last updated 01/21/98].
  • International Agency for Research on Cancer. IARC GLOBOCAN 2002 database.
  • Longnecker MP, Orza MJ, Adams ME, Vioque J, Chalmers TC. A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control. 1990;1:59–68.
  • Lewis S, Campbell S, Proudfoot E, Weston A, Cotter T, Bishop J. Alcohol as a Cause of Cancer. Sydney, Australia: Cancer Institute NSW; 2008.
  • Longnecker MP. Alcohol consumption and risk of cancer in humans: an overview. Alcohol. 1995;12(2):87–96.
  • Williams RR, Hor JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients interview study from the Third National Cancer Survey. J Natl Cancer Inst. 1977;58:525–547.
  • Macfarlane GJ, Macfarlane TV, Lowenfels AB. The influence of alcohol consumption on worldwide trends in mortality from upper aerodigestive tract cancers in men. J Epidemiol Community Health. 1996;50(6):636–639.
  • Launoy G, Milan CH, Faivre J, Pienkowski P, Milan CI, Gignoux M. Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer. 1997;75(9):1389–1396.
  • Gapstur SM, Potter JD, Sellers TA, Folsom AR. Increased risk of breast cancer with alcohol consumption in postmenopausal women. Am J Epidemiol. 1992;136:1221–1231.
  • Rosenberg L, Metzger LS, Palmer JR. Alcohol consumption and risk of breast cancer: a review of the epidemiological evidence. Epidemiol Rev. 1993;15:133–144.
  • Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control. 1994;5:73–82.
  • Van den Brandt PA, Goldbolm A, van‘t Veer P. Alcohol and breast cancer: results from the Netherlands Cohort Study. Am J Epidemiol. 1995;141:907–915.
  • Swanson CA, Coates RJ, Malone KE, et al. Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology. 1997;8:231–237.
  • Vachon CM, Cerhan JR, Vierkant RA, Sellers TA. Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota Breast Cancer Family Study. Cancer. 2001;92(2):240–248.
  • Horn-Ross PL, Canchola AJ, West DW, et al. Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev. 2004;13(3):405–411.
  • Li Y, Baer D, Friedman GD, Udaltsova N, Shim V, Klatsky AL. Wine, liquor, beer and risk of breast cancer in a large population. Eur J Cancer. 2009;45(5):843–850.
  • Newcomb PA, Nichols HB, Beasley JM, et al. No difference between red wine or white wine consumption and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(3):1007–1010.
  • Smith-Warner SA, Spiegelman D, Yaun SS, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998;279(7):535–540.
  • Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiological and experimental evidence and potential mechanisms. JAMA. 2001;286:2143–2151.
  • Mørch LS, Johansen D, Thygesen LC, et al. Alcohol drinking, consumption patterns and breast cancer among Danish nurses: a cohort study. Eur J Public Health. 2007;17(6):624–629.
  • Kuper H, Ye W, Weiderpass E, et al. Alcohol and breast cancer risk: the alcoholism paradox. Br J Cancer. 2000;83(7):949–951.
  • Gronbaek M, Becker U, Johansen D, et al. Type of alcohol consumed and mortality from all causes, coronary heart disease and cancer. Ann Intern Med. 2000;133:411–419.
  • Briggs NC, Levine RS, Bobo LD, Haliburton WP, Brann EA, Hennekens CH. Wine drinking and risk of non-Hodgkin’s lymphoma among men in the United States: a population-based case-control study. Am J Epidemiol. 2002;156(5):454–462.
  • Gronbaek M, Becker U, Johansen D, Tonnesen H, Jensen G, Sorensen TI. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. Br Med J. 1998;317(7162):844–847.
  • Prescott E, Gronbaek M, Becker U, Sorensen TI. Alcohol intake and the risk of lung cancer: influence of type of alcoholic beverage. Am J Epidemiol. 1999;149(5):463–470.
  • Barstad B, Sørensen TI, Tjønneland A, et al. Intake of wine, beer and spirits and risk of gastric cancer. Eur J Cancer Prev. 2005;14(3):239–243.
  • Chao C. Associations between beer, wine, and liquor consumption and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2436–2447.
  • Pedersen A, Johansen C, Grønbaek M. Relations between amount and type of alcohol and colon and rectal cancer in a Danish population based cohort study. Gut. 2003;52(6):861–867.
  • Sutcliffe S, Giovannucci E, Leitzmann MF, et al. A prospective cohort study of red wine consumption and risk of prostate cancer. Int J Cancer. 2007;120(7):1529–1535.
  • Ames B, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90:7915–7922.
  • Fenech M, Crott J, Turner J, Brown S. Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within the cytokinesis-block micronucleus assay: description of the method and results for hydrogen peroxide. Mutagenesis. 1999a;14:605–612.
  • Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The HUman MicroNucleus Project–An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res. 1999b;428:271–283.
  • De Flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 1997;11(12):1021–1031.
  • Andreassi MG, Botto N, Colombo MG, Biagini A, Clerici A. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular disease? Env Mol Mutagenesis. 2000;35:265–269.
  • Izzotti A, Camoirano A, Cartiglia C, Tampa E, De Flora S. Formation of DNA adducts in the aorta of smoke-exposed rats, and modulation by chemopreventative agents. Mutat Res. 2001;494:97–106.
  • Botto N, Rizza A, Colombo MG, et al. Evidence for DNA damage in patients with coronary artery disease. Mutation Res. 2001;493:23–30.
  • Fenech M, Stockley C, Aitken C. Moderate wine consumption protects against hydrogen peroxide-induced DNA damage. Mutagenesis. 1997;12:289–296.
  • Leighton F, Cuevas A, Guasch V, et al. Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans. Drugs Exp Clin Res. 1999;25(2–3):133–141.
  • Greenrod W, Fenech M. The principal phenolic and alcoholic components of wine protect human lymphocytes against hydrogen peroxide-and ionising radiation-induced DNA damage in vitro. Mutagenesis. 2003;18(2):119–126.
  • Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res. 1993;285:35–44.
  • Greenrod W, Stockley CS, Burcham P, Abbey M, Fenech M. Moderate acute intake of de-alcoholised red wine, but not alcohol, is protective against radiation-induced DNA damage ex vivo – results of a comparative in vivo intervention study in Mutat Res. 2005;591(1–2):290–301.
  • Casalini C, Lodovici M, Briani C, et al. Effect of complex polyphenols and tannins from red wine (WCPT) on chemically induced oxidative DNA damage in the rat. Eur J Nutr. 1999;38(4):190–195.
  • Dihal AA, de Boer VC, van der Woude H, et al. Quercetin, but not its glycosidated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats. J Nutr. 2006;136(11):2862–2867.
  • Franke AA, Custer LJ, Cooney RV, Tanaka Y, Xu M, Dashwood RH. Inhibition of colonic aberrant crypt formation by the dietary flavonoids (+)-catechin and hesperidin. Adv Exp Med Biol. 2002;505:123–133.
  • Tsan MF, White JE, Maheshwari JG, Bremner TA, Sacco J. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br J Haematol. 2000;109(2):405–412.
  • Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res. 2001;7(5):1466–1473.
  • Stivala LA, Savio M, Carafoli F, et al. Specific structural determinants are responsible for the antioxidant and the cell cycle effects of resveratrol. J Biol Chem. 2001;276(25):22586–22594.
  • Elattar TM, Virji AS. The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells. Anticancer Res. 1999a;19(6B):5407–5414 .
  • Hsieh TC, Burfeind P, Laud K, et al. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int J Oncol. 1999a;15(2):245–252.
  • Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. Resveratrol increases nitric oxide synthase, p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 1999b;59(11):2596–2601.
  • Hsieh TC, Wu JM. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res. 1999c;249(1):109–115.
  • Damianaki A, Bakogeorgou E, Kampa M, et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem. 2000;78(3):429–441.
  • Kampa M, Hatzoglou A, Notas G, et al. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer. 2000;37(2):223–233.
  • Mutoh M, Takahashi M, Fukuda K, et al. Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship. Jpn J Cancer Res. 2000;91(7):686–691.
  • Latruffe N, Delmas D, Jannin B, Malki MC, Passilly-Degrace P, Berlot JP. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent. Int J Mol Med. 2002;10(6):755–760.
  • Elattar TM, Virji AS. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs. 1999b;10(2):187–193.
  • Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates hostdefense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer. 2001;39(1):102–107.
  • Wolter F, Akoglu B, Clausnitzer A, Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr. 2001;131(8):2197–2203.
  • Pohland T, Wagner S, Mahyar-Roemer M, Roemer K. Bax and Bak are the critical complementary effectors of colorectal cancer cell apoptosis by chemopreventive resveratrol. Anticancer Drugs. 2006;17(4):471–478.
  • AusDiab Steering Committee. Diabetes and associated disorders in Australia. The accelerating epidemic. 2001 Report. Melbourne, Australia: International Diabetes Institute; 2001.
  • Feener EP, King GL. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit. 2001;1(3):74–82.
  • Gu W, Pagel PS, Warltier DC, Kersten JR. Modifying cardiovascular risk in diabetes mellitus. Anesthesiology. 2003;98(3):774–849.
  • Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med. 2003;163(1):33–40.
  • Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden. J Hum Hypertens. 2003;17(1):37–44.
  • Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med. 2003;138(7):593–602.
  • de Vegt F, Dekker JM, Groeneveld WJ, et al. Moderate alcohol consumption is associated with lower risk for incident diabetes and mortality: the Hoorn Study. Diabetes Res Clin Pract. 2002;57(1):53–56.
  • Wannamethee SG, Shaper AG, Perry IJ, Alberti KG. Alcohol consumption and the incidence of type II diabetes. J Epidemiol Community Health. 2002;56(7):542–548.
  • Wannamethee SG, Camargo CA Jr, Manson JE, Willett WC, Rimm EB. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med. 2003;163:1329–1336.
  • Ajani UA, Gaziano JM, Lotufo PA, et al. Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation. 2000b;102:500–505.
  • Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790–797.
  • Carlsson S, Hammar N, Efendic S, Persson PG, Ostenson CG, Grill V. Alcohol consumption, Type 2 diabetes mellitus and impaired glucose tolerance in middle-aged Swedish men. Diabet Med. 2000;17(11): 776–778.
  • Kao WH, Puddey IB, Boland LL, Watson RL, Brancati FL. Alcohol consumption and the risk of type 2 diabetes mellitus: atherosclerosis risk in communities study. Am J Epidemiol. 2001;154(8):748–757.
  • Avogaro A, Watanabe RM, Gottardo L, de Kreutzenberg S, Tiengo A, Pacini G. Glucose tolerance during moderate alcohol intake: insights on insulin action from glucose/lactate dynamics. J Clin Endocrinol Metab. 2002;87:1233–1238.
  • Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719–725.
  • Ajani UA, Hennekens CH, Spelsberg A, Manson JE. Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians. Arch Intern Med. 2000a;160:1025–1030.
  • Solomon CG, Hu FB, Stampfer MJ, et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation. 2000;102:494–499.
  • Bantle AE, Thomas W, Bantle JP. Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism. 2008;57(2):241–245.
  • Ceriello A, Bortolotti N, Motz E, et al. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism. 1999a;48(12):1503–1508.
  • Diwadkar VA, Anderson JW, Bridges SR, Gowri MS, Oelgten PR. Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples. Proc Soc Exp Biol Med. 1999;222(2):178–184.
  • Ceriello A, Bortolotti N, Motz E, et al. Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. Eur J Clin Invest. 2001;31(4):322–328.
  • Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care. 1999b;22(12):2084–2085.
  • Ceriello A, Taboga C, Tonutti L, et al. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. Diabetologia. 1996;39:469–473.
  • Landrault N, Poucheret P, Krosniak M, et al. Effect of a polyphenolcenriched Chardonnay white wine in diabetic rats. In: Meeting the consumer challenge. Proceedings of the 26th World Congress and 81st General Assembly of the Office International de al Vigne et du Vin, Adelaide, Australia. 11–17 October 2001. p. 304–312.
  • Nyström T, Nygren A, Sjöholm A. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin Sci (Lond). 2006;110(6):673–681.
  • Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol. 2000;59(7):865–870.
  • Feng YH, Zou JP, Li XY. Effects of resveratrol and ethanol on production of pro-inflammatory factors from endotoxin activated murine macrophages. Acta Pharmacol Sin. 2002;23(11):1002–1006.
  • Marfella R, Cacciapuoti F, Siniscalchi M, et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus. Diabet Med. 2006;23(9):974–981.
  • Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–131.
  • Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–438.
  • Dixon JB, Dixon ME, O’Brien PE. Reduced plasma homocysteine in obese red wine consumers: a potential contributor to reduced cardiovascular risk status. Eur J Clin Nutr. 2002;56(7):608–614.
  • Sonnenberg L, Pencina M, Kimokoti R, et al. Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res. 2005;13:153–162.
  • Athyros VG, Liberopoulos EN, Mikhailidis DP, et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology. 2008;58(6):689–697.
  • Vadstrup ES, Petersen L, Sørensen TI, Grønbaek M. Waist circumference in relation to history of amount and type of alcohol: results from the Copenhagen City Heart Study. Int J Obes Relat Metab Disord. 2003;27(2):238–246.
  • Djousse L, Arneff DK, Eckfeldt JH, Province MA, Singer MR, Ellison RC. Alcohol consumption and the metabolic syndrome: does the type of beverage matter? Obes Res. 2004;12:1375–1385.
  • Rosell M, De Faire U, Hellénius ML. Low prevalence of the metabolic syndrome in wine drinkers–is it the alcohol beverage or the lifestyle? Eur J Clin Nutr. 2003;57(2):227–234.
  • Dixon JB, Dixon ME, O’Brien PE. Elevated homocysteine levels with weight loss after Lap-Band(R) surgery: higher folate and vitamin B(12) levels required to maintain homocysteine level. Int J Obes Relat Metab Disord. 2001;25:219–227.
  • Cravo ML, Gloria LM, Selhub J, et al. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr. 1996;63(2):220–224.
  • Bleich S, Bleich K, Kropp S, et al. Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the French Paradox? Alcohol Alcohol. 2001;36:189–192.
  • Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337(4):230–236.
  • Bellamy M, McDowell I, Ramsay M, et al. Hyperhomocysteinemia after oral methionine load acutely Impairs endothelial function in healthy adults. Circulation. 1998;98(18):1848–1852.
  • Welsh G, Loscalzo J. Mechanisms of disease: Homocysteine and Atherothrombosis. N Engl J Med. 1998;338(15):1042–1050.
  • Cook S, Huglin O, Eglim, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome in eNOS null mice. Swiss Med Wkly. 2003;1339(25–26):360–363.
  • Monti LD, Barlassina C, Citterio L, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003;52(5):1270–1275.
  • Fernandez ML, Ruiz R, Gonzalez MA, et al. Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb Haemost. 2004;92(2):413–418.
  • Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: the ATTICA study. Am Heart J. 2004;148(4):733–738.
  • Liu Y, Burdon KP, Langefeld CD, et al. T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. J Am Soc Nephrol. 2005;16(4):1085–1090.
  • Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100(5):1230–1239.
  • Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 2000;49(7):1231–1238.
  • Lynn MA, Rupnow HL, Kleinhenz DJ, Kanner WA, Dudley SC, Hart CM. Fatty acids differentially modulate insulin-stimulated endothelial nitric oxide production by an Akt-independent pathway. J Investig Med. 2004;52(2):129–136.
  • Cuevas AM, Guasch V, Castillo O, et al. A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers. Lipids. 2000;35:143–148.
  • Stoclet JC, Kleschyov A, Andriambeloson E, Diebolt M, Andriantsitohaina R. Endothelial no release caused by red wine polyphenols. J Physiol Pharmacol. 1999;50(4):535–540.
  • Diebolt M, Bucher B, Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension. 2001;38(2):159–165.
  • Benito S, Lopez D, Sáiz MP, et al. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol. 2002;135(4): 910–916.
  • Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106(13):1614–1617.
  • Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a poly-phenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002;106(13):1652–1658.
  • Wallerath T, Poleo D, Li HG, Forstermann U. Red wine increases the expression of human endothelial nitric oxide synthase–a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol. 2003;41(3):471–478.
  • Hollenberg NK. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Curr Hypertens Rep. 2003;5(4):287–288.
  • Ndiaye M, Chataigneau T, Chataigneau M, Schini-Kerth VB. Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway. Br J Pharmacol. 2004;142(7):1131–1136.
  • Khan NQ, Lees DM, Douthwaite JA, Carrier MJ, Corder R. Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin Sci (London). 2002;103(Suppl 48):72S–75S.
  • Zou JG, Wang ZR, Huang YZ, Cao KJ, Wu JM. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med. 2003;11(3):317–320.
  • 151 Cervilla JA, Prince M, Mann A. Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry. 2000;68:622–626.
  • Dent OF, Sulway MR, Broe GA, et al. Alcohol consumption and cognitive performance in a random sample of Australian soldiers who served in the second world war. Br Med J. 1997;314:1655–1657.
  • Dufouil C, Ducimetiere P, Alperovitch A. Sex differences in the association between alcohol consumption and cognitive performance. Am J Epidemiol. 1997;146:405–412.
  • Harwood DG, Barker WW, Loewenstein DA, et al. A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics. Neurology. 1999;52:551–556.
  • Hendrie HC, Gao S, Hall KS, Hui SL, Unverzagt FW. The relationship between alcohol consumption, cognitive performance, and daily functioning in an urban sample of older black Americans. J Am Geriatr Soc. 1996;44:1158–1165.
  • Leibovici D, Ritchie K, Ledesert B, Touchon J. The effects of wine and tobacco consumption on cognitive performance in the elderly: a longitudinal study of relative risk. Int J Epidemiol. 1999; 28:77–81.
  • Teri L, Hughes JP, Larson EB. Cognitive deterioration in Alzheimer’s disease: behavioural and health factors. J Gerontol. 1990;42:3–10.
  • Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH. Alcohol consumption and cognitive function in late life: A longitudinal community study. Neurology. 2005;65:1210–1217.
  • Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F. Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med. 2005;352(3):245–253.
  • McDougall GJ Jr, Becker H, Areheart KL. Older males, cognitive function, and alcohol consumption. Issues Ment Health Nurs. 2006;27(4):33–53.
  • Reid MC, Van Ness PH, Hawkins KA, Towle V, Concato J, Guo Z. Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care. J Geriatr Psychiatry Neurol. 2006;19(2):98–105.
  • Wright CB, Elkind MSV, Rundek T, Boden-Albala B, Paik MC, Sacco RL. Alcohol intake, carotid plaque, and cognition: the Northern Manhattan Study. Stroke. 2006;37:1160–1164.
  • Bond GE, Burr RL, McCurry SM, Rice MM, Borenstein AR, Larson EB. Alcohol and cognitive performance: a longitudinal study of older Japanese Americans. The Kame Project. Int Psychogeriatr. 2005;17(4):653–668.
  • Espeland MA, Coker LH, Wallace R, et al. Association between alcohol intake and domain-specific cognitive function in older women. Neuroepidemiology. 2006;27(1):1–12.
  • Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J. 1999;319:1523–1528.
  • Mukamal KJ, Longstreth WT Jr, Mittleman MA, Crum RM, Siscovick DS. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the Cardiovascular Health Study. Stroke. 2001;32:1939–1946.
  • Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT Jr, Mittleman MA, Siscovick DS. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA. 2003;289:1405–1413.
  • Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol. 1998;56(4):385–431.
  • French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B. A case-control study of dementia of the Alzheimer type. Am J Epidemiol. 1985;121(3):414–421.
  • Launer LJ, Feskens EJ, Kalmijn S, Kromhout D. Smoking, drinking, and thinking. The Zutphen Elderly Study. Am J Epidemiol. 1996;143(3):219–227.
  • Galanis DJ, Joseph C, Masaki KH, Petrovitch H, Ross GW, White L. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study. Am J Public Health. 2000;90(8):1254–1259.
  • Ruitenberg A, van Swieten JC, Witteman JC, et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet. 2002;359:281–286.
  • Huang W, Qui L, Fratiglioni E. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J Clin Epidemiol. 2002;55:959–964.
  • Anekonda TS, Reddy PH. Neuronal protection by sirtuins in Alzheimer’s disease. J Neurochem. 2006;96(2):305–313.
  • Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 1999;22(6):273–280.
  • Henn C, Loffelholz K, Klein J. Stimulatory and inhibitory effects of ethanol on hippocampal acetylcholine release. Naunyn Schmiedebergs Arch Pharmcol. 1998;357:640–647.
  • Orgogozo JM, Dartigues JF, Lafont S, et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris). 1997;153(3):185–192.
  • Lemeshow S, Letenneur L, Dartigues JF, Lafont S, Orgogozo JM, Commenges D. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol. 1998;148(3):298–306.
  • Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156:445–453.
  • Truelsen T, Thudium D, Gronbaek M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology. 2002;59(9):1313–1319.
  • Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of dementia. J Am Geriatr Soc. 2004;52(4):540–546.
  • Selkoe DJ. Alzheimer’s disease: genotypes, phenotypes, and treatments. Science. 1997;275(5300):630–631.
  • Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem. 2005;280(45):37377–37382.
  • Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am J Clin Nutr. 2000;71(2):630S–636S.
  • Chung KK, Dawson VL, Dawson TM. New insights into Parkinson’s disease. J Neurol. 2003;250(Suppl 3):III15–24.
  • Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson’s disease. Science. 2003;302(5646):819–822.
  • Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson’s disease? Brain Res Mol Brain Res. 2005;134(1):18–23.
  • Morano A, Jiménez-Jiménez FJ, Molina JA, Antolín MA. Risk-factors for Parkinson’s disease: case-control study in the province of Cáceres, Spain. Acta Neurol Scand. 1994;89(3):164–170.
  • Ragonese P, Salemi G, Morgante L, et al. A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson’s disease. Neuroepidemiology. 2003;22(5):297–304.
  • Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;86(5): 1486–1494.
  • Fall PA, Fredrikson M, Axelson O, Granérus AK. Nutritional and occupational factors influencing the risk of Parkinson’s disease: a case-control study in southeastern Sweden. Mov Disord. 1999;14(1):28–37.
  • Ono K, Hirohata M, Yamada M. Alpha-synuclein assembly as a therapeutic target of Parkinson’s disease and related disorders. Curr Pharm Des. 2008;14(30):3247–3266.
  • Simons LA, McCallum J, Friedlander Y, Simons J. Alcohol intake and survival in the elderly: a 77 month follow-up in the Dubbo study. Aust NZ J Med. 1996;26:662–670.
  • Simons LA, McCallum J, Friedlander Y, Ortiz M, Simons J. Moderate alcohol intake is associated with survival in the elderly: the Dubbo study. Med J Aust. 2000;172:121–124.
  • Simons LA, Simons J, McCallum J, Friedlander Y. Lifestyle factors and risk of dementia: Dubbo Study of the elderly. Med J Aust. 2006;184(2):68–70.